Fund Details
Jennison Associates
Overview
Investment management firm managing over $93 billion for clients.
Founded
1969
Deals ยท 12mo
0
Stage focus
Series B
Series C
Series D
Geographic focus
France
United States
Sector focus
Financial Services
Venture Capital
Investment portfolio
16rounds
| NAME | DATE | SIZE | |
|---|---|---|---|
Corvus Pharmaceuticals | Sep 2015Participated | $75 MSeries B | |
Syndax Pharmaceuticals | Aug 2015Participated | $80 MSeries C | |
Wave Life Sciences | Aug 2015Participated | $66 MSeries B | |
Ovid Therapeutics | Aug 2015Participated | $75 MSeries B | |
Editas Medicine | Aug 2015Participated | $120 MSeries B | |
GenSight Biologics | Jul 2015Participated | $36 MSeries B | |
Afferent Pharmaceuticals | Jul 2015Participated | $55 MSeries C | |
Cogent Biosciences | Jun 2015Participated | $65 MSeries B | |
REGENXBIO | May 2015Participated | $71 MSeries D | |
Natera | Apr 2015Participated | $56 MOther Equity | |
Aeglea BioTherapeutics | Mar 2015Participated | $44 MSeries B | |
Aduro BioTech Inc. | Jan 2015Participated | $51 MSeries D | |
Corvus Pharmaceuticals | Sep 2015Participated | $75 MSeries B | |
Syndax Pharmaceuticals | Aug 2015Participated | $80 MSeries C | |
Wave Life Sciences | Aug 2015Participated | $66 MSeries B | |
Ovid Therapeutics | Aug 2015Participated | $75 MSeries B | |
Editas Medicine | Aug 2015Participated | $120 MSeries B | |
GenSight Biologics | Jul 2015Participated | $36 MSeries B | |
Afferent Pharmaceuticals | Jul 2015Participated | $55 MSeries C | |
Cogent Biosciences | Jun 2015Participated | $65 MSeries B | |
REGENXBIO | May 2015Participated | $71 MSeries D | |
Natera | Apr 2015Participated | $56 MOther Equity | |
Aeglea BioTherapeutics | Mar 2015Participated | $44 MSeries B | |
Aduro BioTech Inc. | Jan 2015Participated | $51 MSeries D |
16 Items
16
Items
...
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Series B | 0 | 7 |
| Series C+ | 0 | 6 |
| Other Equity | 0 | 3 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Mar '13 | 1 |
| Apr '13 | 0 |
| May '13 | 0 |
| Jun '13 | 0 |
| Jul '13 | 0 |
| Aug '13 | 0 |
| Sep '13 | 0 |
| Oct '13 | 0 |
| Nov '13 | 0 |
| Dec '13 | 0 |
| Jan '14 | 0 |
| Feb '14 | 0 |
| Mar '14 | 0 |
| Apr '14 | 1 |
| May '14 | 0 |
| Jun '14 | 0 |
| Jul '14 | 0 |
| Aug '14 | 1 |
| Sep '14 | 1 |
| Oct '14 | 0 |
| Nov '14 | 0 |
| Dec '14 | 0 |
| Jan '15 | 1 |
| Feb '15 | 0 |
| Mar '15 | 1 |
| Apr '15 | 1 |
| May '15 | 1 |
| Jun '15 | 1 |
| Jul '15 | 2 |
| Aug '15 | 4 |
| Sep '15 | 1 |
| Oct '15 | 0 |
| Nov '15 | 0 |
| Dec '15 | 0 |
| Jan '16 | 0 |
| Feb '16 | 0 |
| Mar '16 | 0 |
| Apr '16 | 0 |
| May '16 | 0 |
| Jun '16 | 0 |
| Jul '16 | 0 |
| Aug '16 | 0 |
| Sep '16 | 0 |
| Oct '16 | 0 |
| Nov '16 | 0 |
| Dec '16 | 0 |
| Jan '17 | 0 |
| Feb '17 | 0 |
| Mar '17 | 0 |
| Apr '17 | 0 |
| May '17 | 0 |
| Jun '17 | 0 |
| Jul '17 | 0 |
| Aug '17 | 0 |
| Sep '17 | 0 |
| Oct '17 | 0 |
| Nov '17 | 0 |
| Dec '17 | 0 |
| Jan '18 | 0 |
| Feb '18 | 0 |
| Mar '18 | 0 |
| Apr '18 | 0 |
| May '18 | 0 |
| Jun '18 | 0 |
| Jul '18 | 0 |
| Aug '18 | 0 |
| Sep '18 | 0 |
| Oct '18 | 0 |
| Nov '18 | 0 |
| Dec '18 | 0 |
| Jan '19 | 0 |
| Feb '19 | 0 |
| Mar '19 | 0 |
| Apr '19 | 0 |
| May '19 | 0 |
| Jun '19 | 0 |
| Jul '19 | 0 |
| Aug '19 | 0 |
| Sep '19 | 0 |
| Oct '19 | 0 |
| Nov '19 | 0 |
| Dec '19 | 0 |
| Jan '20 | 0 |
| Feb '20 | 0 |
| Mar '20 | 0 |
| Apr '20 | 0 |
| May '20 | 0 |
| Jun '20 | 0 |
| Jul '20 | 0 |
| Aug '20 | 0 |
| Sep '20 | 0 |
| Oct '20 | 0 |
| Nov '20 | 0 |
| Dec '20 | 0 |
| Jan '21 | 0 |
| Feb '21 | 0 |
| Mar '21 | 0 |
| Apr '21 | 0 |
| May '21 | 0 |
| Jun '21 | 0 |
| Jul '21 | 0 |
| Aug '21 | 0 |
| Sep '21 | 0 |
| Oct '21 | 0 |
| Nov '21 | 0 |
| Dec '21 | 0 |
| Jan '22 | 0 |
| Feb '22 | 0 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 0 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 0 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 16 |
| Consumer & Lifestyle | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 0 |
| $5M-$10M | 0 |
| $10M-$25M | 0 |
| $25M-$50M | 4 |
| $50M-$100M | 11 |
| $100M-$250M | 1 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 2 of 2 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 15 |
| Europe | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Fidelity Management & Research Company | 7 |
| OrbiMed | 6 |
| Cormorant Asset Management | 5 |
| Cowen Private Investments | 4 |
| Perceptive Advisors | 4 |
| RA Capital Management | 4 |
| Redmile Group | 4 |
| Clough Capital Partners | 3 |
| EcoR1 Capital | 3 |
| Foresite Capital | 3 |
| Alexandria Venture Investments | 2 |
| Ally Bridge Group | 2 |
| Deerfield Management | 2 |
| Domain Associates | 2 |
| F-Prime Capital | 2 |
| Franklin Templeton | 2 |
| Janus Henderson Investors | 2 |
| New Leaf Venture Partners | 2 |
| Novo Holdings | 2 |
| Novo Ventures | 2 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 0 | 0% |
| Participating | 16 | 100% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 0 | 0% |
| Co-led | 0 | 0% |
Lead dynamics requires at least one led deal in this range
Team
Andrew M. Tucker
Managing Director
Benjamin F. Bryan
Managing Director and Equity Research Analyst
Gregory Tuorto
Managing Director and Equity Research Analyst
Jason McManus
Managing Director, Head of Custom Solutions
John D. Saunders
Equity Research Analyst
Kenneth Moore, CFA
Chief Operating Officer
Mark Baribeau, C.F.A.
Managing Director, Head of Global Equity
Michael A. Del Balso
Director of Research for Growth Equity
Spiros Segalas
Founder,President and Chief Investment Officer